Yes, Miralax (polyethylene glycol 3350) can be safely given to a 3-year-old child for constipation.
Polyethylene glycol 3350 is both safe and effective for treating functional constipation in children as young as 6 months of age, making it an appropriate choice for your 3-year-old patient.
Evidence Supporting Use in Young Children
Multiple high-quality pediatric studies demonstrate that PEG 3350 is safe and effective in children well below 3 years of age:
A 2023 controlled trial specifically included infants starting at 6 months of age, treating them for 12 months with excellent safety and efficacy outcomes 1. No severe clinical or biochemical adverse events were registered in this study.
A 2006 randomized trial treated children with chronic constipation for 12 months, showing that 62% of PEG-treated children improved with only one allergic reaction reported among all participants 2. The study confirmed no clinically significant side effects or blood abnormalities.
A 2018 double-blind trial included children as young as 0.5 years (6 months) and found no drug-related serious adverse events over 52 weeks of treatment 3.
Dosing Considerations for a 3-Year-Old
Based on the pediatric research:
- Age 2-4 years: Daily sachet use ranged from 0.1 to 3.5 sachets (each sachet = 17g) 3
- Typical starting approach: Begin with a lower dose and titrate upward as needed
- The medication can be mixed in any beverage of the child's choice, which improves acceptance 4
Safety Profile
The safety data is reassuring:
- Mild, expected side effects include bloating, flatulence, and diarrhea—consistent with any laxative therapy 5
- Adverse events in pediatric studies were mild: nausea (13%), abdominal pain (11%), and vomiting (11%) 4
- No electrolyte disturbances of clinical significance were found in children treated long-term 2, 4
- Better acceptance than alternatives: PEG 3350 showed better compliance (95%) compared to magnesium hydroxide (65%) in head-to-head pediatric trials 2
Important Caveats
While the evidence strongly supports use in 3-year-olds, be aware:
FDA labeling: The over-the-counter product is officially approved only for "occasional constipation" in adults 6, but extensive pediatric research supports its use in children
One case report described potential contamination of generic PEG 3350 with ethylene glycol causing toxicity 7—this appears to be an isolated contamination issue rather than a problem with the medication itself
Duration: While FDA-approved for occasional use, research demonstrates safety for up to 12 months of continuous treatment in children 1, 3, 2
Clinical Bottom Line
For your 3-year-old patient with constipation, PEG 3350 represents a first-line treatment option with strong pediatric safety data extending down to 6 months of age. Start with a lower dose mixed in the child's preferred beverage and titrate based on response. The extensive research base in young children provides confidence that significantly exceeds what the adult-focused FDA labeling might suggest.